title: Successful therapy of treatment-emergent, non-clonal daptomycin-non-susceptible Enterococcus faecium infections.
authors.forename: S Travis
authors.initials: ST
authors.lastname: King
authors.forename: Justin B
authors.initials: JB
authors.lastname: Usery
authors.forename: Katherine
authors.initials: K
authors.lastname: Holloway
authors.forename: Laura
authors.initials: L
authors.lastname: Koeth
authors.forename: Kerry O
authors.initials: KO
authors.lastname: Cleveland
authors.forename: Michael S
authors.initials: MS
authors.lastname: Gelfand
mesh_terms: D000081:Acetamides / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D017576:Daptomycin / Q000494:pharmacology*; D016984:Enterococcus faecium / Q000187:drug effects* / Q000472:pathogenicity; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D000069349:Linezolid; D023303:Oxazolidinones / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D014640:Vancomycin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D000081:Acetamides; D000900:Anti-Bacterial Agents; D023303:Oxazolidinones; D014640:Vancomycin; D000069349:Linezolid; D017576:Daptomycin